[Research Progress in Pathogenesis of Hypertension in Acute Intermittent Porphyria].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 45(1): 129-133, 2023 Feb.
Article
em Zh
| MEDLINE
| ID: mdl-36861166
Acute intermittent porphyria (AIP) has complicated clinical manifestations and is often accompanied by hypertension.AIP may cause hypertension through adrenergic effect,heme deficiency,inflammation,inappropriate secretion of antidiuretic hormone,toxicity of delta-aminolevulinic acid(ALA,aporphyrin precursor),and elevated serum glucose level.The prevention and treatment strategies for AIP accompanied with hypertension mainly include the controlling of porphyria attacks,application of antihypertensive drugs,lifestyle intervention,and management of latent AIP patients.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Porfiria Aguda Intermitente
/
Hipertensão
Tipo de estudo:
Etiology_studies
Limite:
Humans
Idioma:
Zh
Revista:
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
China